RBC
ARKG icon

Romano Brothers & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

Romano Brothers & Co’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-97
Closed -$2.74K – 337
2022
Q4 		$2.74K Buy
+97
New +$3.08K ﹤0.01% 901

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Romano Brothers & Co's ARKG Position: Q1 2023 in Review

Romano Brothers & Co sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 97 shares — an estimated $2.74K sold.

Romano Brothers & Co first reported a position in ARKG in Q4 2022 and held it in 1 quarter. The position peaked at $2.74K in Q4 2022. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • Romano Brothers & Co reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • Romano Brothers & Co sold 97 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $2.74K.
  • Romano Brothers & Co first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 1 quarter.
  • Romano Brothers & Co's ARK Genomic Revolution ETF position peaked at $2.74K in Q4 2022.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.